Skip to main content
Equibles

Robert Lisicki

Board Member

Cadrenal Therapeutics, Inc. (CVKD)

Equibles does not estimate personal net worth.

Get an email with a short summary when Cadrenal Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CVKD alerts

About Robert Lisicki

Robert Lisicki is recorded as Board Member at Cadrenal Therapeutics, Inc. (CVKD) since July 29, 2024. Cadrenal Therapeutics, Inc. reported in an 8-K filed July 18, 2025 that Robert Lisicki resigned as Class II Director, effective July 15, 2025. Cadrenal Therapeutics, Inc. reported in an 8-K filed July 31, 2024 that Robert Lisicki was appointed Class II director, effective July 29, 2024. Cadrenal Therapeutics, Inc. reported in an 8-K filed July 24, 2023 that Robert Lisicki was appointed Class II director, effective July 23, 2023. Cadrenal Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cadrenal Therapeutics, Inc. includes John P. Sharp (CFO), Matthew K. Szot (CFO), Quang X. Pham (CFO, Chief Accounting Officer and Board Member) and 7 others.

“On July 15, 2025, Robert Lisicki (Class II Director), a member of the board of directors (the "Board") of Cadrenal Therapeutics, Inc., a Delaware corporation (the "Company"), notified the Company of his decision to resign from the Board, effective immediately.”
Cadrenal Therapeutics, Inc. Form 8-K, filed July 18, 2025 · Read the filing
“The following two (2) individuals were elected as Class II directors, to serve until the Company’s 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified with the following votes:”
Cadrenal Therapeutics, Inc. Form 8-K, filed July 31, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Cadrenal Therapeutics, Inc.

Recent activity